Advanced search
Publication Cover
Current Eye Research Volume 21, 2000 - Issue 2
Submit an article Journal homepage
44
Views
40
CrossRef citations to date
0
Altmetric
Research Article

Influence of intravenous immunoglobulin therapy on serum levels of anti-ß4 antibodies in ocular cicatricial pemphigoid: A correlation with disease activity

Erik Letko The Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Uveitis and Immunology Service, Harvard Medical School, 2Department of Medicine, NE Baptist Hospital and Department of Oral Medicine and Diagnostic Sciences, Harvard School of Dental Medicine, MA, USA
,
Kailash Bhol The Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Uveitis and Immunology Service, Harvard Medical School, 2Department of Medicine, NE Baptist Hospital and Department of Oral Medicine and Diagnostic Sciences, Harvard School of Dental Medicine, MA, USA
,
C. Stephen Foster The Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Uveitis and Immunology Service, Harvard Medical School, 2Department of Medicine, NE Baptist Hospital and Department of Oral Medicine and Diagnostic Sciences, Harvard School of Dental Medicine, MA, USA
&
A. Razzaque Ahmed The Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Uveitis and Immunology Service, Harvard Medical School, 2Department of Medicine, NE Baptist Hospital and Department of Oral Medicine and Diagnostic Sciences, Harvard School of Dental Medicine, MA, USA
Pages 646-654 | Published online: 02 Jul 2009

Citations (40)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Diya F Mutasim. (2007) Therapy of autoimmune bullous diseases. Therapeutics and Clinical Risk Management 3:1, pages 29-40.
Read now
A Razzaque Ahmed. (2004) Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy. Expert Opinion on Investigational Drugs 13:8, pages 1019-1032.
Read now

Articles from other publishers (38)

Nika Kianfar, Shayan Dasdar, Maryam Daneshpazhooh, Zeinab Aryanian & Azadeh Goodarzi. (2023) A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy. Experimental Dermatology 32:7, pages 934-944.
Crossref
Roberto Maglie, Carolina Vieira De Almeida, Maria Efenesia Baffa, Beatrice Bianchi, Marzia Caproni, Giovanni Di Zenzo, Xiaoguang Li, Yoshiaki Hirako, Takashi Hashimoto, Ignazia Tusa, Matteo Lulli, Elisabetta Rovida & Emiliano Antiga. (2022) Anti‐β4 integrin autoantibodies in patients with mucous membrane pemphigoid: A retrospective analysis from a tertiary centre in Italy. Journal of the European Academy of Dermatology and Venereology 37:2.
Crossref
M. Castel, C. Bédane & P. Joly. (2022) Dermatosis ampollosas autoinmunitarias subepidérmicas. EMC - Dermatología 56:4, pages 1-21.
Crossref
E. Schmidt, H. Rashid, A.V. Marzano, A. Lamberts, G. Di Zenzo, G.F.H. Diercks, S. Alberti‐Violetti, R.J. Barry, L. Borradori, M. Caproni, B. Carey, M. Carrozzo, G. Cianchini, A. Corrà, F.G. Dikkers, C. Feliciani, G. Geerling, G. Genovese, M. Hertl, P. Joly, J.M. Meijer, V. Mercadante, D.F. Murrell, M. Ormond, H.H. Pas, A. Patsatsi, S. Rauz, B.D. van Rhijn, M. Roth, J. Setterfield, D. Zillikens, C.Prost, G. Zambruno, B. Horváth & F. Caux. (2021) European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part II. Journal of the European Academy of Dermatology and Venereology 35:10, pages 1926-1948.
Crossref
Hideyuki Ujiie, Hiroaki Iwata, Jun Yamagami, Takekuni Nakama, Yumi Aoyama, Shigaku Ikeda, Norito Ishii, Keiji Iwatsuki, Michiko Kurosawa, Daisuke Sawamura, Akiko Tanikawa, Daisuke Tsuruta, Wataru Nishie, Wataru Fujimoto, Masayuki Amagai & Hiroshi Shimizu. (2019) Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita). The Journal of Dermatology 46:12, pages 1102-1135.
Crossref
Sepehr Feizi & Danial Roshandel. (2019) Ocular manifestations and management of autoimmune bullous diseases. Journal of Ophthalmic and Vision Research 14:2, pages 195.
Crossref
Durga S. Borkar & Nicholas J. Butler. 2019. Treatment of Non-infectious Uveitis. Treatment of Non-infectious Uveitis 113 129 .
Kyle T. Amber, Roberto Maglie, Farzan Solimani, Rüdiger Eming & Michael Hertl. (2018) Targeted Therapies for Autoimmune Bullous Diseases: Current Status. Drugs 78:15, pages 1527-1548.
Crossref
A. Razzaque Ahmed & Srinivas Kaveri. (2018) Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin. Frontiers in Immunology 9.
Crossref
Kyle T. Amber, Jessica Shiu, Katherine Ferris & Sergei A. Grando. 2018. Biologic and Systemic Agents in Dermatology. Biologic and Systemic Agents in Dermatology 401 423 .
Enno Schmidt & Richard Groves. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition 1 74 .
Munther M. Queisi, Mike Zein, Neerav Lamba, Halea Meese & Charles Stephen Foster. (2016) Update on ocular cicatricial pemphigoid and emerging treatments. Survey of Ophthalmology 61:3, pages 314-317.
Crossref
Iana Turcan & Marcel F. Jonkman. (2014) Blistering disease: insight from the hemidesmosome and other components of the dermal-epidermal junction. Cell and Tissue Research 360:3, pages 545-569.
Crossref
Laura C Huang. (2015) Pseudopemphigoid as caused by topical drugs and pemphigus disease. World Journal of Ophthalmology 5:1, pages 1.
Crossref
Bianka Sobolewska, Christoph Deuter & Manfred Zierhut. (2013) Current Medical Treatment of Ocular Mucous Membrane Pemphigoid. The Ocular Surface 11:4, pages 259-266.
Crossref
L.R. Zakka, P. Reche & A.R. Ahmed. (2011) Role of MHC Class II Genes in the pathogenesis of pemphigoid. Autoimmunity Reviews 11:1, pages 40-47.
Crossref
A. Shadi Kourosh & Kim B. Yancey. (2011) Therapeutic Approaches to Patients with Mucous Membrane Pemphigoid. Dermatologic Clinics 29:4, pages 637-641.
Crossref
C. Bédane & V. Doffoel Hantz. (2011) Pemphigoïde cicatricielle : revue de la littérature. Annales de Dermatologie et de Vénéréologie 138:3, pages 201-208.
Crossref
Batya B. Davidovici & Ronni Wolf. 2011. Emergency Dermatology. Emergency Dermatology 34 49 .
P. Bernard & C. Bédane. (2011) Dermatosis ampollosas autoinmunitarias subepidérmicas. EMC - Dermatología 45:3, pages 1-18.
Crossref
P. Bernard & C. Bédane. (2011) Dermatoses bulleuses auto-immunes sous-épidermiques. EMC - Dermatologie 6:2, pages 1-17.
Crossref
Hakan M. Gürcan, Sunil Jeph & A. Razzaque Ahmed. (2010) Intravenous Immunoglobulin Therapy in Autoimmune Mucocutaneous Blistering Diseases. American Journal of Clinical Dermatology 11:5, pages 315-326.
Crossref
Valérie Doffoel-Hantz, Pierre-Yves Robert & Christophe Bédane. (2010) Pemphigoïde cicatricielle, pemphigoïde des muqueuses. La Presse Médicale 39:10, pages 1049-1057.
Crossref
Norito Ishii, Takashi Hashimoto, Detlef Zillikens & Ralf J. Ludwig. (2009) High-Dose Intravenous Immunoglobulin (IVIG) Therapy in Autoimmune Skin Blistering Diseases. Clinical Reviews in Allergy & Immunology 38:2-3, pages 186-195.
Crossref
Diya F. Mutasim. (2010) Autoimmune Bullous Dermatoses in the Elderly. Drugs & Aging 27:1, pages 1-19.
Crossref
Crispian Scully & Lorenzo Lo Muzio. (2008) Oral mucosal diseases: Mucous membrane pemphigoid. British Journal of Oral and Maxillofacial Surgery 46:5, pages 358-366.
Crossref
Valerie P.J. Saw & John K.G. Dart. (2008) Ocular Mucous Membrane Pemphigoid: Diagnosis and Management Strategies. The Ocular Surface 6:3, pages 128-142.
Crossref
E. Schmidt, T. Meyer-ter-Vehn, D. Zillikens & G. Geerling. (2008) Schleimhautpemphigoid mit okulärer BeteiligungMucous membrane pemphigoid with ocular involvement. Der Ophthalmologe 105:3, pages 285-298.
Crossref
Samih Elchahal, Eric R. Kavosh & David S. Chu. (2008) Ocular Manifestations of Blistering Diseases. Immunology and Allergy Clinics of North America 28:1, pages 119-136.
Crossref
Khwaja A. Rashid, Hakan M. Gürcan & A. Razzaque Ahmed. (2006) Antigen Specificity in Subsets of Mucous Membrane Pemphigoid. Journal of Investigative Dermatology 126:12, pages 2631-2636.
Crossref
Mary Jo. J. Kerns, Julia E. Graves, David I. Smith & Michael P. Heffernan. (2006) Off-Label Uses of Biologic Agents in Dermatology: A 2006 Update. Seminars in Cutaneous Medicine and Surgery 25:4, pages 226-240.
Crossref
Diya F. Mutasim. (2004) Management of autoimmune bullous diseases: Pharmacology and therapeutics. Journal of the American Academy of Dermatology 51:6, pages 859-877.
Crossref
Muna Ahmed, Ghassan Zein, Faizullah Khawaja & C. Stephen Foster. (2004) Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment. Progress in Retinal and Eye Research 23:6, pages 579-592.
Crossref
Shih Wei Yeh, Adnan Q Usman & A.Razzaque Ahmed. (2004) Profile of autoantibody to basement membrane zone proteins in patients with mucous membrane pemphigoid: long-term follow up and influence of therapy. Clinical Immunology 112:3, pages 268-272.
Crossref
Erik Letko, Elisabetta Miserocchi, Yassine J Daoud, William Christen, C.Stephen Foster & A.Razzaque Ahmed. (2004) A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Clinical Immunology 111:3, pages 303-310.
Crossref
Erwin W. Gelfand. (2004) Use of IGIV in the Treatment of Immune-Mediated Dermatologic Disorders. Journal of Investigative Dermatology Symposium Proceedings 9:1, pages 92-96.
Crossref
Diya F Mutasim. (2003) Autoimmune Bullous Dermatoses in the Elderly. Drugs & Aging 20:9, pages 663-681.
Crossref
N SAMI, K C BHOL & A R AHMED. (2002) Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titres to human α 6 integrin . Clinical and Experimental Immunology 129:3, pages 533-540.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.